These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2428825)
21. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). Chalbos D; Vignon F; Keydar I; Rochefort H J Clin Endocrinol Metab; 1982 Aug; 55(2):276-83. PubMed ID: 7045150 [TBL] [Abstract][Full Text] [Related]
22. Progestin stimulation of lactate dehydrogenase in the human breast cancer cell line T-47D. Hagley RD; Hissom JR; Moore MR Biochim Biophys Acta; 1987 Sep; 930(2):167-72. PubMed ID: 2441761 [TBL] [Abstract][Full Text] [Related]
23. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. Yang S; Fang Z; Gurates B; Tamura M; Miller J; Ferrer K; Bulun SE Mol Endocrinol; 2001 Dec; 15(12):2093-105. PubMed ID: 11731611 [TBL] [Abstract][Full Text] [Related]
24. Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture. Malet C; Spritzer P; Guillaumin D; Kuttenn F J Steroid Biochem Mol Biol; 2000 Jun; 73(3-4):171-81. PubMed ID: 10925217 [TBL] [Abstract][Full Text] [Related]
25. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Papa V; Reese CC; Brunetti A; Vigneri R; Siiteri PK; Goldfine ID Cancer Res; 1990 Dec; 50(24):7858-62. PubMed ID: 2253226 [TBL] [Abstract][Full Text] [Related]
26. Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin. Poulin R; Dufour JM; Labrie F Breast Cancer Res Treat; 1989 Jul; 13(3):265-76. PubMed ID: 2667655 [TBL] [Abstract][Full Text] [Related]
27. Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells. Dauvois S; Simard J; Dumont M; Haagensen DE; Labrie F Mol Cell Endocrinol; 1990 Oct; 73(2-3):171-8. PubMed ID: 2269395 [TBL] [Abstract][Full Text] [Related]
28. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
29. Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486. Tseng L; Mazella J; Sun B Endocrinology; 1986 Apr; 118(4):1312-8. PubMed ID: 2936597 [TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies. Elashry-Stowers D; Zava DT; Speers WC; Edwards DP Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062 [TBL] [Abstract][Full Text] [Related]
31. Progestin stimulation of thymidine kinase in the human breast cancer cell line T47D. Moore MR; Hathaway LD; Bircher JA Biochim Biophys Acta; 1991 Feb; 1096(2):170-4. PubMed ID: 2001431 [TBL] [Abstract][Full Text] [Related]
32. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Read LD; Keith D; Slamon DJ; Katzenellenbogen BS Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345 [TBL] [Abstract][Full Text] [Related]
33. Comparative effects of 17 beta-estradiol, progestin R5020, tamoxifen and RU38486 on lactate dehydrogenase activity in MCF-7 human breast cancer cells. Thomas M; Monet JD; Brami M; Dautigny N; Assailly J; Ulmann A; Bader CA J Steroid Biochem; 1989 Feb; 32(2):271-7. PubMed ID: 2921868 [TBL] [Abstract][Full Text] [Related]
34. Estradiol 17 beta-hydroxysteroid dehydrogenase, a marker of breast cancer hormone dependency. Fournier S; Brihmat F; Durand JC; Sterkers N; Martin PM; Kuttenn F; Mauvais-Jarvis P Cancer Res; 1985 Jun; 45(6):2895-9. PubMed ID: 3857123 [TBL] [Abstract][Full Text] [Related]
35. [Estradiol-progesterone interaction in normal and pathological human breast cells]. Mauvais-Jarvis P; Kuttenn F; Gompel A; Malet C; Fournier S Ann Endocrinol (Paris); 1986; 47(3):179-87. PubMed ID: 3535636 [TBL] [Abstract][Full Text] [Related]
36. Failure of progestins to induce estradiol dehydrogenase activity in endometrial carcinoma, in vitro. Satyaswaroop PG; Mortel R Cancer Res; 1982 Apr; 42(4):1322-5. PubMed ID: 6949638 [TBL] [Abstract][Full Text] [Related]
37. Comment on 'Difference between R5020 and the anti progestin RU486 in antiproliferative effects on human breast cancer cells'. Moore MR Breast Cancer Res Treat; 1988 Sep; 12(1):81-2. PubMed ID: 3196889 [No Abstract] [Full Text] [Related]
38. Effects of estradiol and promegestone on human breast cell cultures. An ultrastructural study. Chomette G; Auriol M; Tranbaloc P; Gompel A; Malet C; Kuttenn F Pathol Res Pract; 1986 Jun; 181(3):273-9. PubMed ID: 3748873 [TBL] [Abstract][Full Text] [Related]
39. Sex steroid hormone modulation of NADPH pathways in MCF-7 cells. Thomas M; Bader C; Monet JD Cancer Res; 1990 Feb; 50(4):1195-200. PubMed ID: 2297768 [TBL] [Abstract][Full Text] [Related]